RESUMO
The influence of aromatic substitution on a newly discovered class of inhibitors of dipeptidyl peptidase IV was investigated. A 10(5)-fold increase in potency was achieved by the optimization of aromatic substituents in a parallel chemistry program. The observed SAR could be explained by an X-ray structure of the protein-ligand complex.
Assuntos
Inibidores de Adenosina Desaminase , Glicoproteínas/antagonistas & inibidores , Inibidores de Proteases/química , Pirimidinas/química , Adenosina Desaminase/metabolismo , Glicoproteínas/metabolismo , Inibidores de Proteases/metabolismo , Pirimidinas/metabolismoRESUMO
In a novel series of DPP-IV inhibitors, a large increase of inhibitory activity was achieved by optimisation of aromatic substituents and conformational restriction.
Assuntos
Aminas/química , Dipeptidil Peptidase 4/efeitos dos fármacos , Inibidores Enzimáticos/síntese química , Piridinas/síntese química , Células Cultivadas , Diabetes Mellitus Tipo 2/tratamento farmacológico , Dipeptidil Peptidase 4/metabolismo , Inibidores Enzimáticos/metabolismo , Inibidores Enzimáticos/farmacologia , Hidrocarbonetos Aromáticos/química , Hidrocarbonetos Aromáticos/farmacologia , Concentração Inibidora 50 , Piridinas/metabolismo , Piridinas/farmacologia , Relação Estrutura-AtividadeRESUMO
A recently identified DPP-IV inhibitor (1) was found to induce phospholipidosis and to inhibit CYP3A4. A small series of less lipophilic and less amphiphilic analogues was synthesized in an effort to overcome these issues. One compound from this series was equipotent to 1, did not induce phospholipidosis and showed a reduced CYP3A4 inhibition.